GEN-MKT-18-7897-A
Jul 2, 2026 | Blogs, Environmental / Industrial | 0 comments
Per- and polyfluoroalkyl substances (PFAS) continue to evolve as a regulatory and analytical challenge, but not all PFAS behave the same. One compound increasingly drawing attention is trifluoroacetic acid (TFA), an ultra-short-chain PFAS with properties that make it particularly difficult to monitor.
As regulatory scrutiny increases and detection requirements tighten, laboratories are facing a new question: How can TFA be measured reliably, sensitively, and at scale?
Watch the full webinar on-demand
The growing importance of TFA monitoring
TFA is highly persistent and extremely mobile in water due to its high solubility and low reactivity. Unlike long-chain PFAS, it does not bioaccumulate in the same way, but its widespread presence and increasing detection in food, beverages, and human samples indicate high exposure potential.
Several sources contribute to environmental TFA contamination, including:
While TFA is not yet consistently regulated across regions, momentum is clearly building:
This evolving landscape is driving demand for more robust, validated analytical methods.
Why TFA is challenging to analyze
Despite its small size, TFA presents disproportionately large analytical challenges.
TFA can be introduced from multiple sources, including solvents, labware, and even additives, creating significant background noise that can obscure low-level detection.
Even common reagents can introduce measurable TFA concentrations. For example, acid additives may contribute ng/L to µg/L levels, complicating trace analysis and method consistency.
Matrix interferences, particularly anions, can suppress ionization, impacting quantification and internal standard recovery in real-world water samples.
Confirming TFA using multiple transitions can be difficult, and regulatory guidance may require additional confirmation strategies if secondary transitions are not sufficient.
Together, these challenges make traditional approaches less reliable, especially when labs need high sensitivity, regulatory confidence, and throughput.
A new approach: fast, ultra-sensitive TFA analysis
To address these challenges, a new LC-MS/MS-based methodology has been developed to enable robust, high-throughput TFA analysis across diverse water matrices.
Key capabilities include:
This combination enables laboratories to move beyond experimental workflows toward routine, scalable TFA monitoring.
Designed for real-world laboratory workflows
Beyond analytical performance, workflow simplicity is critical for adoption.
This approach minimizes sample preparation by allowing:
The result is a streamlined workflow that supports both research and regulatory environments, without sacrificing data quality or reproducibility.
Enabling confident decisions in a changing regulatory landscape
As PFAS regulations continue to evolve, laboratories need methods that are not only sensitive, but also:
TFA represents a new frontier in PFAS analysis, where traditional methods often fall short. Advanced LC-MS/MS solutions are helping bridge this gap—enabling labs to generate high-confidence data, even at trace levels.
Watch the full webinar
To explore the methodology in more detail, including validation data, method setup, and real sample analysis:
Access the on-demand webinar
Glycosylation is one of the more structurally diverse and biologically impactful PTMs in protein therapeutics. Both N‑linked and O‑linked glycans influence protein folding, stability, and biological activity. Given these effects on biotherapeutics, glycosylation is a closely monitored critical quality attribute (CQA). Comprehensive and site‑specific characterization of glycosylation is essential for informed decision‑making throughout drug discovery and development.
Warranty expiration is more than an administrative milestone—it is a transition point that can significantly impact instrument uptime, laboratory productivity, operating budgets, and scientific outcomes.
For more than 20 years, the CDCO has supported academic, commercial, and not‑for‑profit drug discovery programs with deep expertise in pharmaceutical lead optimization. Within the bioanalytical group, their role is to enable rapid and reliable decision‑making through quantitative analysis of candidate drugs in biological matrices.
Posted by
You must be logged in to post a comment.
Share this post with your network